Correction to: Platinum nanoparticles in cancer therapy: chemotherapeutic enhancement and ROS generation [0.03%]
致癌疗法中铂类纳米颗粒的化疗增强和ROS生成的纠正评论
Emmanuel Faderin,Terungwa H Iorkula,Omowunmi Rebecca Aworinde et al.
Emmanuel Faderin et al.
Thymoquinone decreases cell proliferation and immune evasion of breast cancer cells by reducing CD55 and CD114 levels [0.03%]
伏马毒素通过降低CD55和CD114水平来减少乳腺癌细胞增殖和免疫逃逸
Nabiha Bashir,Mehreen Ishfaq,Saeeda Munir et al.
Nabiha Bashir et al.
Controlling the proliferation and immune evasion of cancer cells can lead to effective strategies for cancer treatment. Thymoquinone, a bioactive compound derived from Nigella sativa exhibits a potent anti-tumor activity. It can be used as ...
Correction to: Chemotherapy of breast cancer cells alters susceptibility to complement‑mediated opsonization and killing [0.03%]
Correction to: 化疗改变乳腺癌细胞对补体介导的调理作用和杀伤作用的敏感性
Mohamed Hassan Nasraa,Mahmoud Mohamed Bahgat,Michael Kirschfinik
Mohamed Hassan Nasraa
Enhanced antitumor activity of atorvastatin and luteolin, with or without doxorubicin, in a solid Ehrlich carcinoma mouse model: modulation of ABC transporters, telomerase, and cancer stem cells [0.03%]
阿托伐他汀和鼠李素联合或不联合多柔比星对实体艾氏腹水瘤的增效作用：调节ABC转运蛋白、端粒酶以及癌症干细胞
Ghada M Al-Ashmawy,Nahla E El-Ashmawy,Omnia B Hamada et al.
Ghada M Al-Ashmawy et al.
This study evaluated the antitumor efficacy of atorvastatin (ATO) and luteolin (LUT), administered individually or in combination with or without doxorubicin (DOX), in mice bearing solid Ehrlich carcinoma (SEC). Additionally, we examined th...
Trigonelline suppresses the tumor progression via STAT2 signalling pathway in non-Small cell lung carcinoma [0.03%]
trigonnelline通过STAT2信号通路抑制非小细胞肺癌的发展进展
Subhashini Dhayalan,Gajalakshmi Ramarajyam,Aruchamy Mohanprasanth et al.
Subhashini Dhayalan et al.
Trigonelline, a naturally derived bioactive compound, has gained interest for its potential anticancer properties. This study investigates its therapeutic efficacy against A549 lung cancer cells and elucidates the underlying molecular mecha...
A novel matrine derivative exerts antitumor effects against hepatocellular carcinoma by inducing oxidative stress and DNA damage [0.03%]
一种新的小蘖碱衍生物通过诱导氧化应激和DNA损伤来抑制肝细胞癌的作用
Zhouxing Hu,Xingdong Wang,Tingguo Xu et al.
Zhouxing Hu et al.
DNA has long been a major target in the development of anticancer drugs. Natural products, as an important source of antitumor agents, play a key role in cancer prevention and treatment. Matrine is a natural quinoline alkaloid isolated from...
Glioma-Immune crosstalk in the tumor microenvironment: mechanistic insights and therapeutic translation [0.03%]
肿瘤微环境中胶质瘤-免疫互作：机制见解与治疗转化
Saba Yousaf,Sibtain Ahmed,Muhammad Arshad et al.
Saba Yousaf et al.
Tumor progression is governed not only by genetic alterations but also by the dynamic interplay within the tumor microenvironment (TME). In gliomas, this microenvironment is shaped by diverse immune populations, including regulatory T cells...
Patient-derived spheroid culture: A promising in vitro model for drug screening in retinoblastoma [0.03%]
基于患者的类器官培养：视网膜母细胞瘤药物筛选的体外模型
Rathinavel Sethu Nagarajan,Sekaran Balaji,Usha Kim et al.
Rathinavel Sethu Nagarajan et al.
In retinoblastoma (RB), the search for newer therapeutics is a thrust area for better disease management, and there is a lack of in vitro models that recapitulate the clinical scenario. Hence, we aim to establish RB patient-derived spheroid...
Disrupting the USP1-UAF1 deubiquitinase complex: a master regulator of replication stress and frontier target in cancer therapy [0.03%]
靶向破坏USP1-UAF1去泛素化酶复合体——应对复制压力的主宰者和癌症治疗中的前沿药物靶标
Emadeldin M Kamel,Sally Mostafa Khadrawy,Ahmed A Allam et al.
Emadeldin M Kamel et al.
A natural nephroprotective adjuvant for cancer chemotherapy: Rosmarinic acid disrupts IL-17 A-Ferroptosis coupling in Ifosfamide-induced renal injury [0.03%]
内源性化疗肾保护佐剂：玫瑰酸干扰白杨素-17a-铁死亡偶联以改善异环磷酰胺诱导的肾脏损伤
Büşra Süzen Celbek,Hasan Şimşek,Nurhan Akaras et al.
Büşra Süzen Celbek et al.
Rosmarinic acid (RA) is a natural polyphenol with established pleiotropic protective effects. Ifosfamide (IFA) is a potent antineoplastic agent whose clinical utility is severely limited by dose-dependent nephrotoxicity, primarily mediated ...